Noninvasive imaging of brain injuries in premature infants
Noninvasive Noncontact High-Density Optical Imaging of Neonatal Intraventricular Hemorrhage
This study is working on a new, gentle way to check for brain injuries in premature babies who have bleeding in the brain, using special light technology to monitor their blood flow and oxygen levels right at their bedside, helping doctors provide better care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-10817033 on NIH RePORTER |
What this research studies
This research focuses on developing a noninvasive imaging technique to assess brain injuries in premature infants, particularly those suffering from germinal matrix-intraventricular hemorrhage (GM-IVH). By utilizing advanced near-infrared spectroscopy and tomography, the study aims to create a bedside tool that can continuously monitor cerebral blood flow and oxygen levels in these vulnerable patients. The goal is to provide healthcare professionals with reliable methods to evaluate brain injury and the effectiveness of treatments in neonatal intensive care units (NICUs).
Who could benefit from this research
Good fit: Ideal candidates for this research are very low birth weight neonates (less than 1500 grams) who are at risk for GM-IVH and related complications.
Not a fit: Patients who are not premature or do not have very low birth weight may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved monitoring and treatment strategies for brain injuries in premature infants, potentially reducing long-term neurological deficits.
How similar studies have performed: While near-infrared spectroscopy has been used in other contexts, this specific application for high-density imaging in neonates is novel and has not been extensively tested.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Yu, Guoqiang — University of Kentucky
- Study coordinator: Yu, Guoqiang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.